1. **Investigate the structure-activity relationship of crossoseamines A and B (1 and 2).** This could be done by synthesizing analogs of 1 and 2 with different substituents and testing their cytotoxic activity against A549 and L. major. This information could be used to design more potent and selective analogs of 1 and 2.
2. **Explore the mechanism of action of crossoseamines A and B (1 and 2).** This could be done by studying the effects of 1 and 2 on cell cycle progression, apoptosis, and other cellular processes. This information could help to identify the molecular targets of 1 and 2 and could lead to the development of new therapeutic strategies for cancer and leishmaniasis.
3. **Investigate the potential of crossoseamines A and B (1 and 2) for use in combination therapy.** This could be done by testing the effects of 1 and 2 in combination with other cytotoxic agents. This information could help to identify synergistic combinations of drugs that could be used to treat cancer and leishmaniasis more effectively.
4. **Explore the potential of crossoseamines A and B (1 and 2) for use in the treatment of other diseases.** This could be done by testing the effects of 1 and 2 against other pathogens or disease models. This information could help to identify new therapeutic applications for 1 and 2.
5. **Investigate the biosynthetic pathway of crossoseamines A and B (1 and 2).** This could be done by studying the expression of genes involved in the biosynthesis of 1 and 2 in C. chinense. This information could help to identify the enzymes responsible for the biosynthesis of 1 and 2 and could lead to the development of new methods for producing these compounds.